Periostin in vitreoretinal diseases

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Proliferative vitreoretinal diseases such as diabetic retinopathy, proliferative vitreoretinopathy (PVR), and age-related macular degeneration are a leading cause of decreased vision and blindness in developed countries. In these diseases, retinal fibro(vascular) membrane (FVM) formation above and beneath the retina plays an important role. Gene expression profiling of human FVMs revealed significant upregulation of periostin. Subsequent analyses demonstrated increased periostin expression in the vitreous of patients with both proliferative diabetic retinopathy and PVR. Immunohistochemical analysis showed co-localization of periostin with α-SMA and M2 macrophage markers in FVMs. In vitro, periostin blockade inhibited migration and adhesion induced by PVR vitreous and transforming growth factor-β2 (TGF-β2). In vivo, a novel single-stranded RNAi agent targeting periostin showed the inhibitory effect on experimental retinal and choroidal FVM formation without affecting the viability of retinal cells. These results indicated that periostin is a pivotal molecule for FVM formation and a promising therapeutic target for these proliferative vitreoretinal diseases.

Original languageEnglish
Pages (from-to)4329-4337
Number of pages9
JournalCellular and Molecular Life Sciences
Volume74
Issue number23
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Proliferative Vitreoretinopathy
Diabetic Retinopathy
Retinal Vessels
Macular Degeneration
Transforming Growth Factors
Gene Expression Profiling
Blindness
RNA Interference
Developed Countries
Retina
Cell Survival
Up-Regulation
Macrophages
Membranes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Periostin in vitreoretinal diseases. / Yoshida, Shigeo; Nakama, Takahito; Ishikawa, Keijiro; nakao, shintaro; Sonoda, Kohei; Ishibashi, Tatsuro.

In: Cellular and Molecular Life Sciences, Vol. 74, No. 23, 01.12.2017, p. 4329-4337.

Research output: Contribution to journalReview article

@article{865ab90431e442c39e64f4b75eab951e,
title = "Periostin in vitreoretinal diseases",
abstract = "Proliferative vitreoretinal diseases such as diabetic retinopathy, proliferative vitreoretinopathy (PVR), and age-related macular degeneration are a leading cause of decreased vision and blindness in developed countries. In these diseases, retinal fibro(vascular) membrane (FVM) formation above and beneath the retina plays an important role. Gene expression profiling of human FVMs revealed significant upregulation of periostin. Subsequent analyses demonstrated increased periostin expression in the vitreous of patients with both proliferative diabetic retinopathy and PVR. Immunohistochemical analysis showed co-localization of periostin with α-SMA and M2 macrophage markers in FVMs. In vitro, periostin blockade inhibited migration and adhesion induced by PVR vitreous and transforming growth factor-β2 (TGF-β2). In vivo, a novel single-stranded RNAi agent targeting periostin showed the inhibitory effect on experimental retinal and choroidal FVM formation without affecting the viability of retinal cells. These results indicated that periostin is a pivotal molecule for FVM formation and a promising therapeutic target for these proliferative vitreoretinal diseases.",
author = "Shigeo Yoshida and Takahito Nakama and Keijiro Ishikawa and shintaro nakao and Kohei Sonoda and Tatsuro Ishibashi",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s00018-017-2651-5",
language = "English",
volume = "74",
pages = "4329--4337",
journal = "Cellular and Molecular Life Sciences",
issn = "1420-682X",
publisher = "Birkhauser Verlag Basel",
number = "23",

}

TY - JOUR

T1 - Periostin in vitreoretinal diseases

AU - Yoshida, Shigeo

AU - Nakama, Takahito

AU - Ishikawa, Keijiro

AU - nakao, shintaro

AU - Sonoda, Kohei

AU - Ishibashi, Tatsuro

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Proliferative vitreoretinal diseases such as diabetic retinopathy, proliferative vitreoretinopathy (PVR), and age-related macular degeneration are a leading cause of decreased vision and blindness in developed countries. In these diseases, retinal fibro(vascular) membrane (FVM) formation above and beneath the retina plays an important role. Gene expression profiling of human FVMs revealed significant upregulation of periostin. Subsequent analyses demonstrated increased periostin expression in the vitreous of patients with both proliferative diabetic retinopathy and PVR. Immunohistochemical analysis showed co-localization of periostin with α-SMA and M2 macrophage markers in FVMs. In vitro, periostin blockade inhibited migration and adhesion induced by PVR vitreous and transforming growth factor-β2 (TGF-β2). In vivo, a novel single-stranded RNAi agent targeting periostin showed the inhibitory effect on experimental retinal and choroidal FVM formation without affecting the viability of retinal cells. These results indicated that periostin is a pivotal molecule for FVM formation and a promising therapeutic target for these proliferative vitreoretinal diseases.

AB - Proliferative vitreoretinal diseases such as diabetic retinopathy, proliferative vitreoretinopathy (PVR), and age-related macular degeneration are a leading cause of decreased vision and blindness in developed countries. In these diseases, retinal fibro(vascular) membrane (FVM) formation above and beneath the retina plays an important role. Gene expression profiling of human FVMs revealed significant upregulation of periostin. Subsequent analyses demonstrated increased periostin expression in the vitreous of patients with both proliferative diabetic retinopathy and PVR. Immunohistochemical analysis showed co-localization of periostin with α-SMA and M2 macrophage markers in FVMs. In vitro, periostin blockade inhibited migration and adhesion induced by PVR vitreous and transforming growth factor-β2 (TGF-β2). In vivo, a novel single-stranded RNAi agent targeting periostin showed the inhibitory effect on experimental retinal and choroidal FVM formation without affecting the viability of retinal cells. These results indicated that periostin is a pivotal molecule for FVM formation and a promising therapeutic target for these proliferative vitreoretinal diseases.

UR - http://www.scopus.com/inward/record.url?scp=85029487134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029487134&partnerID=8YFLogxK

U2 - 10.1007/s00018-017-2651-5

DO - 10.1007/s00018-017-2651-5

M3 - Review article

C2 - 28913545

AN - SCOPUS:85029487134

VL - 74

SP - 4329

EP - 4337

JO - Cellular and Molecular Life Sciences

JF - Cellular and Molecular Life Sciences

SN - 1420-682X

IS - 23

ER -